In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs.
The following faculty have disclosed:
Rajesh Pahwa, MD, chair for this educational event, receives research funds from Abbott, AbbVie, Alexza, Annovis, Biogen, Bluerock, Bukwang, Cerevel, Global Kinetics, Jazz, Michael J Fox Foundation, Neuroderm, Neuraly, Parkinson’s Foundation, Praxis, Roche, Sage, Scion, Sun Pharma, UCB, and Voyager; and receives consulting fees from Abbott, AbbVie, ACADIA, Acorda, Allevion, Amneal, Artemida, BioVie, CalaHealth, Convatec, Global Kinetics, Inbeeo, Insightec, Jazz, Kyowa, Lundbeck, Merz, Neurocrine, Neuroderm, Ono, PhotoPharmics, Sage, Sunovion, Supernus, UCB and Wren.
Daniel Kremens, MD, JD, faculty for this educational event, receives consulting fees from Teva Pharmaceuticals, Sunovion, Amneal, Avion, Lundbeck, Acadia, USWorldMeds, Supernus, Adamas, Abbvie, Merz, Allergan, Acorda, Kyowa Kirin, Neurocrine, Supernus and Britannia; and receives research funds from Voyager Therapeutics, Revance and Enterin.
Stuart Isaacson, MD, faculty for this educational event, receives research support from Abbvie, Acadia, Acorda, Adamas, Addex, Amneal, Aptinyx, Axial, Benevolent, Biogen, Biovie, Cadent, Cala, Cerecor, Cerevel, Eli Lilly, Enterin, Global Kinetics, Impax, Intec Pharma, Jazz, Kyowa Kirin, Lundbeck, Michael J. Fox Foundation, Neuralys, Neurocrine, Neuroderm, Novartis, Parkinson Study Group, Pharma2B, Praxis, Prilenia, Revance, Roche, Sage, Sanofi, Scion, Stoparkinson, Sunovion, Sun Pharma, Supernus, Teva, Theravance, Transposon and UCB; and receives consulting fees from Abbvie, Acadia, Acorda, Adamas, Addex, Affiris, Alexza, Allergan, Amneal, Britannia, Cala, Cerecor, Cerevel, Enterin, GE Healthcare, Global Kinetics, Impax, Impel, Kyowa Kirin, Lundbeck, Merz, Neurocrine, Neuroderm, Pharma2B, Revance, Roche, Sage, Scion Neurostim, Stoparkinson, Sunovion, Supernus, Teva and UCB.